HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael R Kilbourn Selected Research

Dementia (Dementias)

8/2012Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
6/2011Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography.
4/2010Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael R Kilbourn Research Topics

Disease

6Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2006
3Parkinson Disease (Parkinson's Disease)
08/2012 - 09/2006
3Dementia (Dementias)
08/2012 - 04/2010
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 01/2019
2Gliosis
01/2019 - 12/2018
1Substance-Related Disorders (Drug Abuse)
01/2021
1Autistic Disorder (Autism)
01/2020
1Stroke (Strokes)
01/2020
1Epilepsy (Aura)
01/2020
1Schizophrenia (Dementia Praecox)
01/2020
1Paralysis (Palsy)
01/2020
1Mental Disorders (Mental Disorder)
01/2019
1Disorders of Excessive Somnolence (Hypersomnia)
08/2016
1Neuroinflammatory Diseases
12/2015
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
08/2014
1Osteoporosis
05/2014
1Leukoencephalopathies
08/2011
1Cognitive Dysfunction
04/2010
1Diabetes Mellitus
07/2008
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2003
1Heroin Dependence (Heroin Abuse)
11/2003
1Pain (Aches)
06/2002
1Nociceptive Pain
06/2002

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2021 - 01/2019
3Monoamine Oxidase (MAO)IBA
01/2019 - 12/2015
3Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
08/2011 - 09/2006
2Dopamine (Intropin)FDA LinkGeneric
01/2021 - 06/2011
2dihydrotetrabenazineIBA
08/2011 - 04/2010
2ButyrylcholinesteraseIBA
12/2006 - 01/2006
2Opioid Analgesics (Opioids)IBA
11/2003 - 06/2002
2mu Opioid Receptors (mu Opioid Receptor)IBA
11/2003 - 06/2002
1Fluorine-18IBA
01/2019
1tau Proteins (tau Protein)IBA
01/2019
1Carbon-11IBA
01/2019
1Tetrabenazine (Nitoman)FDA Link
01/2019
1Clarithromycin (Biaxin)FDA LinkGeneric
08/2016
1RadiopharmaceuticalsIBA
08/2014
1Lansoprazole (Prevacid)FDA LinkGeneric
08/2014
1Cysteine (L-Cysteine)FDA Link
05/2014
1Cathepsin KIBA
05/2014
1Peptide Hydrolases (Proteases)FDA Link
05/2014
1Cholinergic Agents (Cholinergics)IBA
08/2012
1Amyloid (Amyloid Fibrils)IBA
06/2011
1Glucose (Dextrose)FDA LinkGeneric
04/2010
1Amyloid beta-PeptidesIBA
11/2009
1Peptides (Polypeptides)IBA
11/2009
1LigandsIBA
07/2008
1Insulin (Novolin)FDA Link
07/2008
1Biomarkers (Surrogate Marker)IBA
09/2006
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2006
1AcetylcholinesteraseIBA
01/2006
1EnzymesIBA
01/2006
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2006
1Heroin (Diamorphine)IBA
11/2003
1carfentanil (carfentanyl)IBA
11/2003
1Hydromorphone (Dilaudid)FDA LinkGeneric
11/2003
1Opiate AlkaloidsIBA
06/2002
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2002
1Opioid Receptors (Opioid Receptor)IBA
06/2002
1Analgesics (Analgesic Drugs)IBA
06/2002

Therapy/Procedure

2Denervation
08/2012 - 08/2011
1Activities of Daily Living (ADL)
09/2006
1Therapeutics
01/2006